Industry Analysis

  The  kidney dialysis equipment market  is expected to reach USD 1,761 Million by 2030 at 6.80% CAGR during the forecast period 2022-2030. CKD or chronic kidney disease is a chronic condition which seriously impacts a patient’s quality of life. Kidney dialysis is the most preferred treatment for severe conditions where both the kidney of a person is damaged, but this treatment is also occasionally used for treating patients with a single damaged kidney. Every day, the kidney of a healthy person filters about 150 quarts of blood. Should an individual’s kidney fail to function efficiently automatically the waste will get collected in the blood resulting in coma and even death. Here dialysis will act as the savior. It will stop the toxin and waste products formation in the blood. It is an artificial kidney that is used for filtering the blood of the patient during kidney failure, kidney dysfunction and kidney damage and for removing surplus impurities from kidneys. Request ...

  The  Polycystic Ovarian Syndrome Market  is anticipated to reach USD 3468.54 Million by 2030 at 4.80% CAGR during the forecast period 2022-2030. The polycystic ovarian syndrome market is expected to witness tremendous growth owing to the rising prevalence of polycystic ovarian syndrome. Other key factors such as the growing obesity among women, increase in hormonal disorders in women, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, increasing occurrence of diabetes in women, and others are contributing towards the growth of the market. However, factors such as high cost of diagnostic procedures, expensive treatments, and side effects associated with drugs are expected to hinder the market growth during the forecast period. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/6295 Segmentation The global polycystic ovarian syndrome market is segmented on the basis of diagnosis, treat...

  The  breast biopsy market  is projected to reach USD 1104 million by 2027 at CAGR of 10.10%. A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body. Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer. This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement. There are various types of biopsy procedures that are used depending upon the different techniques like vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). These are recommended by the doctor based on the size, location, and other characteristics of the breast abnormality. The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast c...

  Acknowledging the traction this market perceives today, Market Research Future (MRFR) in its recently published study report asserts that the  Ayurveda Market  is expected to reach USD 23,810.04 million by 2030 at CAGR 15.06% during the forecast 2021-2030. Ayurveda, although a traditional Indian healing system, worldwide, it has long been recognized as an effective alternative treatment, being offered in therapeutic practices. It takes a holistic approach to health, promoting daily maintenance of the mind, body, and soul, striking a balance between the two which further reduces the risk of needing major medical intervention in the future. Alongside the recognition, Ayurveda has also garnered huge popularity across the globe. Online and store-based distribution channels are availing various therapeutic-grade Ayurveda products, offering the convenience of purchasing. Resultantly, the global Ayurveda market is growing pervasively, witnessing augmented uptake of A...

  Epigenetics market  size is expected to reach USD 4.5 billion by 2030 at 15.8% CAGR during the forecast period 2022-2030. Epigenetics refers to the analysis and study of heritable changes in the gene function. It does not involve the study of changes in the DNA sequence like in a chromosome, phenotypic affecting the gene activity, or expression. Sources of these heritable changes could be external such as environmental factors, as well as biological factors such as age or disease. Some examples of Epigenetics are histone modification, which refers to the alteration of genes expressions without altering the DNA sequence, and DNA methylation. The primary factor responsible for the ascension of the global epigenetics market is the increasing prevalence of cancer. According to the statistics revealed by the World Health Organization, cancer was responsible for around 8.8 million deaths in 2015, indicating nearly 1 in 6 patients. Further, as per the Centers for Disease Control an...

  Morphine is a pain medication which directly acts on the central nervous system to decrease acute and chronic pain. As per the report published by Market Research Future (MRFR), the  Medical Morphine Market  is expected to reach USD 21,433.27 Million by 2030 at 7.20% CAGR during the forecast period 2022-2030. Market Drivers: Morphine is a quintessential pain medication which is prescribed by licensed medical practitioners to the patients with acute or chronic pain. The increased use of morphine by the patients suffering from cancer, arthritis, myocardial infarction and other diseases is driving the expansion of the global medical morphine market. Increasing geriatric population and prevalence of diseases like arthritis, cancer and others are inducing demand for morphine in the market, leading to the growth of the global medical morphine market. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/6084 The application of medical morphine...

  The  biological safety cabinet market  is projected to reach USD 1,91.36 Million by 2030 at 7.60% CAGR during the forecast period 2022-2030. Biological safety cabinets, simply put, are ventilated and enclosed laboratory equipment that offers safety at the time of working with biohazard or contaminated materials. It is generally categorized based on exhaust systems, velocities, airflow pattern, and construction. Biological safety cabinets are equipped with HEPA filters for maintaining the environment’s sterility against biohazard materials.  Various factors are propelling the global biological safety cabinet market growth. According to the new MRFR report, such factors include increasing investments in life sciences and the medical sector, booming pharmaceutical & biotechnology sectors, adoption of innovative research set up products, demand for modernization of laboratories for reducing human efforts, growing research and development activities, and favorable r...

  Medical device connectivity market  is projected to register a valuation of USD 9.4 billion by 2030 at a CAGR of 25.2% over the forecast period 2022-2030. The increased saturation rates achieved by electronic health records is expected to galvanize the development of the medical device connectivity market. Reports that assess the Healthcare IT industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. The expansion of health information exchange systems in healthcare organizations is creating a favorable impetus for the expansion of the medical device connectivity market. Furthermore, the infiltration of EHRs via the partnership between IT service contributors and healthcare service suppliers. The development of a unified platform to generate uniformities by the reorganization of physician workflows is expected to unlock increased growth potential for the market in the impe...

  Market Research Future’s (MRFR) latest report predicts that the  urethral stricture market  is expected to grow at a 7.30% CAGR, along with a market valuation worth USD 1.53 billion during the forecast period. Urethral stricture is a chronic disease which can narrow the urethral opening due to injuries, scars, genetic disorders and sexually transmitted diseases. This can restrict urine flow and be a major cause of various urological disorders. The urethral stricture market is expanding steadily due to the rise in the treatment of injuries, kidney stones, poor dietary habits, obesity, and other medical conditions that require urethral stents, dilators, and catheters. Apart from this, improving healthcare facilities and growing awareness about the disease and treatment positively affect the market size globally. Surgeries like urethral dilations are popular in countries like India and China due to their high efficiency and low cost. Furthermore, the introduction of new an...

  The  Ophthalmic Equipment Market  is expected to reach USD 63.9 Billion by 2030 at 5.10% CAGR during the forecast period 2022-2030. The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period.  Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/5973 Segmentation On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contac...

  The  Recombinant DNA Technology Market  is expected to reach USD 1.06 trillion by 2030 at 4.9% CAGR during the forecast period 2022-2030. The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region holds the largest market share of the global recombinant DNA technology market due to the presence of effective regulations pertaining to the approval of recombinant therapeutics and other Genetically Modified (GM) products. F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, Monsanto Company, Eli Lilly and Company, and Biogen Inc. are some of the major companies operating in this space that are responsible for the growth of the Americas recombinant DNA technology market. The  recombinant dna process  that can alter and manipulate the DNA sequences is known as recombinant DNA technology. Recombinant DNA technology is used in genetically modified organisms and products...